F de Vathaire1, A Shamsaldin, E Grimaud
1INSERM, U. 351, Département de biostatistique et d'épidémiologie, Institut Gustave-Roussy, Villejuif, France.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Childhood cancer survivors receiving radiotherapy face a higher risk of developing a second solid malignant neoplasm (SMN). This risk is elevated for younger patients and peaks 15-20 years post-irradiation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: